InnoPharmax Inc. (TPEX:4172)

InnoPharmax Revenue

InnoPharmax had revenue of 45.12M TWD in the half year ending June 30, 2026, with 94.79% growth. This brings the company's total for the last twelve months to 67.47M, up 20.97% year-over-year. In the year 2025, InnoPharmax had annual revenue of 68.99M with 113.60% growth. That makes InnoPharmax the 42,303rd largest company in the world by revenue and 2,135th in Taiwan.

• Revenue (ttm): 67.47M
• Revenue Growth: +20.97%
• P/S Ratio: 17.62
• Revenue / Employee: 2.04M
• Employees: 33
• Market Cap: 1.19B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Mainland China 32.85M 47.6%
• Taiwan 27.87M 40.4%
• Others 8.26M 12.0%

Fiscal year ended Dec 31, 2025 See the full InnoPharmax breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	68.99M	36.69M	113.60%
Dec 31, 2024	32.30M	-13.78M	-29.90%
Dec 31, 2023	46.07M	16.94M	58.15%
Dec 31, 2022	29.13M	-18.93M	-39.38%
Dec 31, 2021	48.06M	-88.82M	-64.89%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 17, 2026

Data Sources Report a data error